FDA Adverse Event Injury Summary report: N

INRATIO

MDR report key: 2132487 · Received June 8, 2011

Report

Report Number
2027969-2011-01279
Event Type
Injury
Date Received
June 8, 2011
Date of Event
May 7, 2011
Report Date
June 8, 2011
Manufacturer
ALERE SAN DIEGO, INC.
Product Code
GJS
PMA / PMN Number
K021923
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL LOT#: 243934. INVESTIGATION PENDING.

Description of Event or Problem · 1

CUSTOMER ALLEGES DISCREPANT RESULTS WITH METER COMPARED TO LAB: DATE: (B)(6) 2011, LOT 243104 INRATIO: 3.8, (B)(4), INRATIO: 4.8, LAB: 1.8, LOT 243934 INRATIO: 5.0. PT'S TARGET THERAPEUTIC RANGE IS 2.5 - 3.0. PT PRESENTED IN EMERGENCY ROOM ON (B)(6) 2011 WITH EDEMA AND LEG PAIN. PHYSICIAN DID SIDE BY SIDE COMPARISON BETWEEN METER AND LAB. PT WAS TREATED FOR ASTHMA AND SUB-THERAPEUTIC INR.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INRATIO PROTHROMBIN TIME TEST GJS ALERE SAN DIEGO, INC. 100071 243104

Patients

Seq Age Sex Outcome Treatment
1 Other